Recent study of our group demonstrated that the downregulation of ERβ in MDA-MB-231 breast cancer cells significantly reduced the aggressiveness of these cells through the inhibition of EMT accompanied by important morphological alterations4. The gene discussed is ESR2; the disease is breast cancer.